Merck KGaA falls on lackluster guidance for 2026
Source: SeekingAlpha
2026-03-05 12:39:19 ET
More on Merck KGaA
- Merck KGaA (MKKGY) Q4 2025 Press Conference Call Transcript
- Merck KGaA 2025 Q4 - Results - Earnings Call Presentation
- Merck KGaA 2025 Q4 - Results - Earnings Call Presentation
- Merck KGaA Non-GAAP EPS of €8.34, revenue of €21.1B; introduces FY26 outlook
- Seeking Alpha’s Quant Rating on Merck KGaA
Read the full article on Seeking Alpha
For further details see:
Merck KGaA falls on lackluster guidance for 2026
Sanofi
NASDAQ: SNY
SNY Trading
-0.34% G/L:
$44.005 Last:
1,196,253 Volume:
$44.06 Open:
SNY Latest News
February 23, 2026 01:42:29 pm
Kraig Biocraft Laboratories Featured on the Cover of National Geographic
February 18, 2026 08:45:56 am
It's Not Synthetic, It's Real. Kraig Labs Nears Spider Silk Breakthrough
SNY Stock Data
$119,804,457,217
2,430,957,423
N/A
389
N/A
Pharmaceuticals
Healthcare
FR
Paris
